Reclazepam
From Wikipedia, the free encyclopedia
Reclazepam
|
|
Systematic (IUPAC) name | |
2-[7-chloro-5-(2-chlorophenyl)-2,3-dihydro -1,4-benzodiazepin-1-yl]-1,3-oxazol-4-one | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C18H13Cl2N3O2 |
Mol. mass | 374.221 |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Reclazepam is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and has a short duration of action.[1]
[edit] References
|